Status:
UNKNOWN
Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill
Lead Sponsor:
Ariel University
Collaborating Sponsors:
Maccabi Healthcare Services, Israel
Conditions:
Attention Deficit Disorder
Eligibility:
All Genders
20-60 years
Phase:
PHASE2
PHASE3
Brief Summary
Randomized clinical trial in which individuals who have been diagnosed with ADHD and are regularly treated with Methylphenidate will be test for cognitive performance and will be randomly examined in ...
Detailed Description
The rationale of this clinical trial is to identify the intervention that best contributes to better cognition results of adults with ADHD's: physical activity, drug or a combination of the two? The s...
Eligibility Criteria
Inclusion
- \* Insured by Maccabi Health Services
- Diagnosed with ADHD by Neurologist/Psychiatrist/Developmental Doctor
- Take Methylphenidate as part of the treatment for ADHD AND have agreed to not take the drug if asked to
- Understand the language and simple instruction
- Willing to participate in the study and sign the agreement form
Exclusion
- Suffer from heart disease or chronic respiratory illness
- Women who are pregnant
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05243186
Start Date
October 1 2021
End Date
October 1 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ariel University
Ariel, Israel, 40700